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Abstract
Background/Aim. Injury-induced anergy is one of the key
factors contributing to trauma victims’ high susceptibility to
sepsis. This group of patients is mostly of young age and it is
therefore essential to be able to predict as accurately as possi-
ble the development of septic complications, so appropriate
treatment could be provided. The aim of this study was to as-
sess kinetics of interleukin (IL) -6 and -10, phospholipase A2-
II and C-reactive protein (CRP) in severely traumatized pa-
tients and explore the possibilities for early detection of po-
tentially septic patients. Methods. This prospective study in-
cluded 65 traumatized patients with injury severity score (ISS)
> 18, requiring treatment at surgical intensive care units, di-
vided into two groups: 24 patients without sepsis and 41 pa-
tients with sepsis. C-reactive protein, IL-6 and -10 and phos-
pholipase A2 group II, were determined within the first 24
hours, and on the second, third and seventh day of hospitali-
zation. Results. Mean values of IL-6 and phospholipase A2-II
in the patients with and without sepsis did not show a statisti-
cally significant difference on any assessed time points. In the
septic patients with ISS 29–35 and > 35 on the days two and
seven a statistically significantly lower level of IL-10 was
found, compared with those without sepsis and with the same
ISS. C-reactive protein levels were significantly higher in septic
patients with ISS 18–28 on the first day. On the second, third
and seventh day CRP levels were significantly lower in the
groups of septic patients with ISS 29–35 and > 35, than in
those with the same ISS but without sepsis. Conclusion.
Mean levels of CRP on the first day after the injury may be
useful predictor of sepsis development in traumatized patients
with ISS score 18–28. Mean levels of CRP on the days two,
three and seven after the injury may be a useful predictor of
sepsis development in traumatized patients with ISS score
more than 28. Mean levels of IL-10 on the second and sev-
enth day after the injury may be a useful predictor of sepsis
development in traumatized patients with ISS score > 28.
Key words:
wounds and injuries; trauma severity indices; C-
reactive protein; interleukin-6; interleukin-10; group II
phospholipases A2; sensitivity and specificity.
Apstrakt
Uvod/Cilj. Anergija izazvana povredom jedan je od najva-
žnijih faktora koji uslovljavaju predispoziciju bolesnika sa
teškim povredama za nastanak sepse. Grupa povređenih
bolesnika najčešće je mlađeg životnog doba, pa je izuzetno
važno što ranije predvideti nastanak sepse, kako bi se pra-
vovremeno sprovelo odgovarajuće lečenje. Cilj ove studije
bio je da se ispita kinetika interleukina-6 i -10, fosfolipaze
A2-II i C-reaktivnog proteina (CRP) kod teško povređenih
bolesnika i mogućnosti ranog otkrivanja bolesnika sa rizi-
kom od nastanka sepse. Metode. Sprovedena je prospekti-
vna studija koja je obuhvatila 65 povređenih sa skorom te-
žine povrede > 18 koji su lečeni u hiruškoj jedinici Intenzi-
vne nege Urgentnog centra Kliničkog centra Srbije, podelje-
nih u dve grupe: 24 povređena kod kojih se tokom hospita-
lizacije nije razvila sepsa i 41 povređeni kod kojih se razvila
sepsa. Koncentracije IL-6 i -10, fosfolipaze A2-II i CRP u
serumu bolesnika određivani su tokom prva 24 h, sa ponav-
ljanim merenjima drugog, trećeg i sedmog dana hospitaliza-
cije.  Rezultati. Prosečna koncentracija IL-6 i fosfolipaze
A2-II u grupama bolesnika sa i bez sepse nisu se statistički
značajno razlikovale na dan prijema, kao ni drugog, trećeg i
sedmog dana hospitalizacije. Kod bolesnika sa sepsom i
skorom težine povrede 29–35 i > 35, u odnosu na bolesnike
bez sepse sa istim skorom težine povrede, drugog, trećeg i
sedmog dana registrovana je statistički značajno niža prose-
čna koncentracija CRP, a drugog i sedmog dana niža prose-
čna koncentracija IL-10. Prosečne koncentracije CRP bile su
značajno više na dan prijema kod bolesnika sa sepsom i sa
skorom težine povrede 18–28. Zaključak. Koncentracija
CRP prvog dana povrede mogući je prediktor razvoja sepse
kod povređenih sa skorom težine povrede 18–28. Ukoliko
je skor težine povrede veći od 28, koncentracija CRP dru-
gog, trećeg i sedmog dana posle povrede, kao i koncentra-
cija IL-10 drugog i sedmog dana korisna je za identifikova-
nje bolesnika koji će razviti sepsu.
Ključne reči:
povrede; povrede, indeksi težine; sepsa; C-reaktivni
protein; interleukin-6; interleukin-10; fosfolipaze A2;
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Introduction
A cytokine cascade activated in response to injury con-
sists of a complex biochemical network with diverse effects
on an injured host. Traumatic injury leads to the systemic in-
flammatory response syndrome (SIRS) followed by a period
of recovery mediated by compensatory anti-inflammatory re-
sponse (CARS), which may induce a prolonged immunosup-
pressed state 
1, 2. Injury-induced anergy is one of the key
factors contributing to trauma victims’ high susceptibility to
sepsis 
3, 4.
Unlike other patients׳ groups with sepsis, trauma pa-
tients are mostly young and with unremarkable past medical
history. Studies demonstrate that the degree of an initial in-
jury is important in determining patient’s susceptibility to
post-traumatic complications, but the issue of secondary sur-
gical procedures acting as additional inflammatory insults
(second hit) and a genetic predisposition are suspected to be
responsible for different outcomes 
1. These factors can ex-
plain why some patients develop serious post-traumatic
complications and others do not, despite the same injury se-
verity scores.
Numerous studies indicate that development of sepsis
begins before clinical manifestations 
1, 5. In a great number of
patients clinically full-blown sepsis is a stage with not much
left to be done. It is therefore essential to be able to predict as
accurately as possible the development of sepsis and deter-
mine early indicators of sepsis, so appropriate treatment
could be provided. The aim of this study was to determine
kinetics of interleukin (IL)-6, IL-10, phospholipase (PL) A2-
II and C-reactive protein (CRP) in traumatized septic patients
and assess the possibility of early detection of patients who
will develop sepsis following severe trauma.
Methods
This prospective study included 65 patients with severe
trauma treated surgically or conservatively at surgical inten-
sive care units of the Clinical Center of Serbia. Patients with
primary neurosurgical injury were not included in the study.
The entry criteria were: injury severity score (ISS) > 18 (se-
vere injury), age range 16 to 65, admission to the hospital
within the first 24 hours following the injury, survival longer
than 48 h. The patients with severe trauma were divided into
two groups: 24 patients without sepsis and 41 patients with
sepsis.
Markers and mediators of inflammation were deter-
mined in all patients within the first 24 hours after the
trauma, immidiately after admittance to the hospital, and on
the second, third and seventh day of hospitalization. Phos-
pholipase A2-II (PLA2-II) concentration was determined us-
ing enzyme-linked immunoadsorbent assay (ELISA; Boe-
hringer Mannheim GmbH, Germany). Reference range was
0–6 ng/mL. The reference range for PLA2-II, which is not a
routine test, was determined from the samples of 120 healthy
control group subjects 
6. C-reactive protein concentration
was determined by immunonephelometry (the Behring laser
nephelometer; normal value <  9mg/mL). Using immunotech
test based on “sandwich” enzyme immunodetermination,
concentration of interleukins was determined. The reference
range for IL-6 was 0–8 pg/mL, and for IL-10 was 0–10
pg/mL.
Sepsis was diagnosed according to the American Col-
lege of Chest Physicians/Society of Critical Care Medicine
Consensus Conference Committee 
7.
One-way analysis of variance was applied to compare
group mean values. The χ
2 test for contingency tables was
used to compare frequencies of injured patients with ISS
score above and below 29 (median value) in different groups.
Values  p < 0.05  or  p  <  0.01 were considered significant.
Kaplan-Meier diagram was used to illustrate mortality and
survival of septic and non-septic patients per hospital days.
Results
Ratio of male to female was 52 : 13, which is common
for traumatic injuries. Average age of patients was
47.13 ± 15.03 years. Two thirds of patients (n = 43; 66.1%)
were surgically treated, while 22 patients (33.9%) were ei-
ther not operated on or had undergone minor surgical inter-
vention under local anesthesia. Length of stay was 23.85 ±
5.94 days, ranging from 2 days (which was entry criterion) to
131 days. Injury severity score ranged from 18 to 45 in all
included patients, mean value being 30.48 ± 6.23. Ten pa-
tients had ISS > 35 defining critical injury, while other 55
patients had severe injury. More than one half of patients
(n  =  41; 63.07%) had sepsis. Overall mortality rate was
50.76% (33 patients died, 32 survived). Mortality rate in the
septic patients was 75.6%.
Sepsis was diagnosed between the third and the four-
teenth day of hospitalization. By the day five of hospitaliza-
tion, it was diagnosed in 56% of patients, reaching 96% by
the eleventh day of hospital stay (Figure 1).
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Fig. 1 – Number of patients with development of sepsis per
hospital day
Mean values of CRP (mg/L), IL-6, IL-10 and PLA2 II
(ng/L) for both groups per days of hospitalization are shown
in Table 1. A statistically significant difference was found in
CRP levels between the patients with and without sepsis on
the second day (Table 1). A statistically significant differ-
ence was found in IL-10 levels in two patient groups on the
first and second day (Table 1). Levels of IL-6 and PLA2-II
were not found to be statistically significantly different be-
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A statistically significant difference was not found in
frequencies of injured patients with ISS score above and be-
low 29 (median value) in different groups (Table 2).
The patients were then divided into three groups, ac-
cording to the severity of injury and ISS level: the group I (ISS
18–28), group II (ISS 29–35) and group III (ISS > 35. Inter-
leukine-6 levels did not differ statistically in the patients with
and without sepsis, regardless of the ISS score group. Interleu-
kine-10 levels did not differ statistically in the ISS group 18–
28. A statistically significant lower IL-10 was found in the sep-
tic patients with ISS 29–35 and >  35, compared with those
without sepsis on the days two and seven (Table 3).
No statistical difference was found in PLA2-II levels
among the septic and non septic patients (Table 4). On the
first day CRP levels were significantly higher in the septic
patients with ISS 18–28. It should be noted that on the sec-
Table 1
C-reactive protein (CRP), interleukin (IL)-6, IL-10 and phospholipase A2-II (PLA2-II) daily levels
(shown as mean ± SD)
Hospital
day
Presence
of sepsis CRP IL-10 IL-6 PLA2-II
+ 171.72 ± 13.70 182.09 ± 34.17* 563.70 ± 89.53 82.33 ± 15.29 1
– 170.64 ± 24.90 293.25 ± 101.68 517.33 ± 114.4 80.53 ± 18.94
+ 190.35 ± 16.86* 115.29 ± 20.69
† 412.58 ± 76.44 84.66 ± 13.10 2
– 223.72 ± 27.66 247.50 ± 98.91 451.33 ± 114.4 87.13 ± 26.70
+ 186.30 ± 14.94 115.70 ± 39.12 280.00 ± 54.19 82.41 ± 11.09 3
– 218.33 ± 28.32 77.46 ± 25.66 252.92 ± 105.0 87.13 ± 26.70
+ 194.84 ± 15.66 78.14 ± 21.23 208.28 ± 49.90 78.68 ± 14.15 7
– 192.56 ± 36.03 185.00 ± 142.74 344.60 ± 289.92 80.32 ± 37.61
*p < 0.05; 
†p < 0.01; p – derived from ANOVA (analysis of variance)
Table 2
Frequencies of injured patients with injury severity score (ISS) above and below 29
(median value) in the groups with and without sepsis
Presence of sepsis ISS > 29 ISS ≤ 29 Total
+2 3 1 8 4 1
–1 4 1 0 2 4
Total 37 28 65
χ
2 = 0.1893, p = ns
Table 3
Interleukin(IL)-6 and IL-10 daily levels (shown as mean ± SE) range in patients with different injury severity score (ISS)
values range in the groups with and without sepsis
ISS 18–28 ISS 29–35 ISS 36–45
Sepsis Sepsis Sepsis Interleu-
kins
Hospital
day Yes (n = 14) No (n = 9) Yes (n = 19) No (n = 12) Yes (n = 8) No (n = 3)
1 325.80 ± 113,46 180.00 ± 80.71 607.21 ± 142.86 619.28 ± 194.83 816.57 ± 191.62 975.33 ± 261.87
2 238.90 ± 98.25 222.83 ± 125.25 442.00 ± 123.03 541.86 ± 194.68 650.57 ± 162.17 678.33 ± 165.44
3 218.60 ± 87.28 65.17 ± 20,21 234.07 ± 75.86 373.83 ± 203.94 459.57 ± 129.59 528.50 ± 125.50
IL-6
7 128.25 ± 74.43 24.50 ± 4.50 152.54 ± 38.70 558.00 ± 472.49 363.63 ± 142.58 381.00 ± 
1 109.20 ± 35.17 120.00 ± 56.05 217.00 ± 67.28 326.37 ± 163.23 216.43 ± 41.55 584.00 ± 286.88
2 79.40 ± 25.56 63.33 ± 24.16 125.64 ± 36.27* 325.37 ± 174.65 145.86 ± 43.30* 326.00 ± 262.24
3 52.40 ± 17.81 29.67 ± 12.14 148.93 ± 84.85 125.67 ± 48.54 139.71 ± 24.67 116.00 ± 41.00
IL-10
7 20.25 ± 6.50 18.00 ± 13.00 75.00 ± 26.82* 296.33 ± 228.85 122.50 ± 53.04* 143.00 ± 
*p < 0.05
Table 4
C-reactive protein (CRP) and phospholipase A2II (PLA2-II) daily levels (shown as mean ± SE) in patients with different
injury severity score (ISS) values shown as range in groups with and without sepsis
ISS 18–28 ISS 29–35 ISS 36–45
Sepsis Sepsis Sepsis Parame-
ters Hospital
day yes (n = 14) no (n = 9) yes (n = 19) no (n = 12) yes (n = 8) no (n = 3)
1 172.96 ± 19.28* 97.81 ± 24.30 160,23 ± 24.40 218.62 ± 38.12 196.87 ± 22.80 205.33 ± 12.91
2 178.63 ± 24.90 134.30 ± 15.81 184.15 ± 29.06* 282.75 ± 42.74 225.62 ± 30.59* 249.00 ± 46.50
3 172.11 ± 25.55 146.19 ± 29.27 174.17 ± 19.94* 267.70 ± 40.51 239.97 ± 38.46* 316.00 ± 58.00
CRP
7 166.34 ± 28.95 105.80 ± 21.42 190.92 ± 21.84* 291.71 ± 52.99 250.50 ± 30.86* 302.00 ± 
1 61.96 ± 18.60 33.20 ± 17.59 70.11 ± 24.35 105.05 ± 30.00 147.02 ± 36.80 128.40 ± 33.34
2 53.71 ± 18.04 41.34 ± 15.08 85.53 ± 20.81 139.58 ± 37.57 136.80 ± 26.39 155.63 ± 24.14
3 54.50 ± 15.89 40.39 ± 16.39 79.43 ± 16.13 127.82 ± 48.91 140,75 ± 22.55 110.00 ± 9.00
PLA2-II
7 49.54 ± 16.03 21.55 ± 8.54 82.60 ± 26.00 147.50 ± 74.61 113.09 ± 14.58 104.50 ± 
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ond, third and seventh day CRP levels were significantly
lower in the groups of septic patients with ISS 29–35 and
> 35, than in those without sepsis.
Discussion
Traumatized patients typically show increased inflam-
matory mediators levels early on admission. These levels
then gradually normalize within days. If a second rise occurs,
this is usually an indicator of complications development
(may include systemic infections). Inflammatory mediator
level increase or decrease is always present earlier than the
clinical symptoms of sepsis 
5.
Mortality rate of the septic patients in our study was
rather high (75.6%). Other authors reported mortality rate
in such patients ranging from 24% to 80% 
8. The patients
included in our study, however, had significantly higher
ISS mean value (30.48 ± 6.23). Bearing in mind severity of
injuries, high percentage of surgically treated patients, sig-
nificant number of patients on prolonged mechanical ven-
tilation, it is not surprising. Recently, studies have reported
a gender difference in a host defence after trauma, hemor-
rhage and sepsis 
9. The imbalance in pro- and anti-
inflammatory cytokines due to secondary operation after
trauma promotes immunological dysfunction that results in
a significant morbidity 
10.
A group II phospholipase A2 belongs to a family of
acute phase proteins and participates in the host response to
inflammation  via the production of proinflammatory
arachidonic acid metabolites. Several authors investigated
the role of PLA2-II in patophysiology of sepsis and multi-
ple trauma 
11–13. In these studies it was reported that PLA2-
II concentration and kinetics correlate reasonably well with
progression and outcome of sepsis. Furthermore, studies
report no significant rise in serum concentration of this en-
zyme 24 hours after trauma or surgery 
11. This is somewhat
different from our results, although mean levels of PLA2-II
in our study are lower on day one of hospitalization than on
the following days. It should be emphasized, however, that
some patients included in our study (particularly those from
remote areas of the country), were admitted to hospital af-
ter a longer period of time than in studies done by other
authors (always within 24 hours from the injury). This may
be the reason for somewhat higher PLA2-II levels in our
patients compared with subjects in other studies. No sig-
nificant difference in PLA2-II serum concentration was
found between patients with and without sepsis. It may be a
result of later development of infectious complications in
severely traumatized patients due to immunosuppression
(the second hit theory).
Epidemiological data show evidence of a correlation
between increased IL-6 levels after trauma and the ISS, the
incidence of complications and mortality 
14, 15. Interleukin-
6 can be seen as marker for the severity of trauma and a
resource in triage, diagnosis and prognosis 
15. Most
authors agree that an early increased IL-6 level can be
marker for a high risk of complications and organ fail-
ure 
14, 15. According to previous studies a threshold level of
800 pg/mL on admission might be a good indicator of dif-
ferentiating between patients with or without organ fail-
ure 
15. There is a lot of evidence that IL-6 concentration is
in a good correlation with severity and outcome of sepsis
in humans 
15. It was reported that septic patients admitted
in intensive care unit had high levels of IL-6, which cor-
related well with severity of the disease (septic shock) and
mortality 
15. Several studies reported that IL-6 concentra-
tions correlated well with late development of sepsis and
resulting mortality rate in patients urgently admitted to
intensive care units 
14, 15.
Mean levels of IL-6 in our patients were very high,
especially on the first and second day of hospitalization.
Some authors always include cytokine status when strati-
fying injured patients based on severity of the injury and
expected outcome 
16. According to these models, cytokine
concentrations are classified in four groups with an ade-
quate prognostic significance (number of points) 
14. Al-
most half the patients in our study (45%) fell into the third
(IL-6  >  250 pg/L) and fourth (IL-6  >  500 pg/L) group,
predicting adverse outcome. Although some authors de-
scribe significant IL-6 increase on the first, or even second
day after trauma, most report that the window closes after
three days, implying that levels of IL-6 have no prognostic
value after that point 
15. We came to the same conclusions
in our study. We found a significant decrease of IL-6 after
the second day of hospitalization. Unfortunately, IL-6
level was not particulary useful in early identification of
patients who will develop sepsis. Daily values of IL-6 did
not differ significantly between the patients with and with-
out sepsis.
Interleukin-10 plays an important role in the anti-
inflammatory response. This protein is produced simultane-
ously with the pro-inflammatory cytokines, but peaks hours
later. One of the functions of IL-10 is the negative feedback
on the production of TNF-α, IL-6 and IL-8.
Increased levels of IL-10 have been shown to correlate
with the development of sepsis or adverse outcome during
sepsis. However, IL-10 is unable to discern outcome or se-
verity of illness on an individual level 
16. In addition, the
biological activity of IL-10 is dependent on the pH and
temperature, which is often altered in severely injured or
septic patients.
In vitro experiments show that human monocytes pro-
duce IL-10 following lipopolysacharide stimulation, but later
than tumor necrosis fator (TNF)-α, IL-1, IL-6, or IL-8. The
presence of anti IL-10 antibodies in culture results in an in-
creased production of these cytokines, especially TNFα and
IFN-γ, thus implying the regulatory role of IL-10 
17.
Our study confirms its protective role. In patients with-
out sepsis mean values of IL-10 are higher on all days except
the third one. Statistically significant difference was found in
IL-10 levels between two patient groups on the first
(p < 0.05) and second day (p < 0.01). Interleukin-10 has ki-
netics similar to IL-6.
We did not analyze the ratio between interleukins in
question, wich was suggested as a predictive factor in some
studies 
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Amongst biomarkers, CRP proved to be useful in the
infection diagnosis, infection prediction and monitoring re-
sponse to antibiotics 
19. However, there is still some debate
concerning a correlation between its serum concentrations
and sepsis severity 
19. In our study, all investigated patients
had CRP levels higher than normal. The septic patients with
less severe trauma (ISS 18–28) had higher CRP levels than
those without sepsis. This is an expected finding. The septic
patients with ISS over 28 had lower CRP levels than the pa-
tients with the same ISS without sepsis. We speculate that
these critically injured patients developed anergy, hepatic
malfunction, and consequently relatively lower levels of
CRP for sepsis.
Conclusion
Mean levels of CRP on the first day after the injury may be
useful predictor of sepsis development in traumatized patients
with ISS score 18–28. Mean levels of CRP on day two, three
and seven after the injury may be useful predictors of sepsis de-
velopment in traumatized patients with ISS score more than 28.
Mean levels of IL-10 on the second and seventh day
after the injury may be a useful predictor of sepsis develop-
ment in traumatized patiemts with ISS score > 28.
Interleukin-6 and PLA2 II kinetics in the first seven
days after trauma does not differentiate patients with and
without sepsis.
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